The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The bmi-1 gene was first isolated as an oncogene that cooperates with c-myc in the generation of mouse lymphomas. We subsequently identified Bmi-1 as a transcriptional repressor belonging to the mouse Polycomb group. The Polycomb group comprises an important, conserved set of proteins that are required to maintain stable repression of specific target genes, such as homeobox-cluster genes, during development. In mice, the absence of bmi-1 expression results in neurological defects and severe proliferative defects in lymphoid cells, whereas bmi-1 overexpression induces lymphomas. Here we show that bmi-1-deficient primary mouse embryonic fibroblasts are impaired in progression into the S phase of the cell cycle and undergo premature senescence. In these fibroblasts and in bmi-1-deficient lymphocytes, the expression of the tumour suppressors p16 and p19Arf, which are encoded by ink4a, is raised markedly. Conversely, overexpression of bmi-1 allows fibroblast immortalization, downregulates expression of p16 and p19Arf and, in combination with H-ras, leads to neoplastic transformation. Removal of ink4a dramatically reduces the lymphoid and neurological defects seen in bmi-1-deficient mice, indicating that ink4a is a critical in vivo target for Bmi-1. Our results connect transcriptional repression by Polycomb-group proteins with cell-cycle control and senescence.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although specific mechanisms are as yet unknown, the senescence response appears to result in a reorganization of chromatin, at least some aspects of which require pRB activity (Jacobs et al., 1999; Leung et al., 2001; Bandyopadhyay et al., 2002; Itahana et al., 2003; Narita et al., 2003; Zhang et al., 2003, 2005).”
From Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors (2005) · cites this paper as Jacobs et al., 1999
In the citing paper
“Therefore, p16INK4A mediated senescence can be induced via disruption of PRC1/PRC2 complex components such as CBX7, BMI1 or EZH2 followed by decrease in levels of H3K27me3 (Jacobs et al., 1999; Bracken et al., 2003, 2007; Gil et al., 2004).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Jacobs et al., 1999
In the citing paper
“The molecular mechanisms underlying this derepression are not completely understood but have been associated with loss of polycomb group of proteins but independent of p53 (Jacobs et al., 1999; Bracken et al., 2007).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Jacobs et al., 1999
In the citing paper
“Because several studies have established a role for the polycomb group protein Bmi1 in the regulation of p16Ink4a (26–28), we analyzed the levels of Bmi1.”
From Age-Dependent Decline in β-Cell Proliferation Restricts the Capacity of β-Cell Regeneration in Mice (2009) · cites this paper as [27]
In the citing paper
“Overexpression of BMI1 [80], CBX7 [81], or CBX8 [82] results in the direct repression of p16 and senescence delay in human and mouse cells.”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [80]
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Role of the INK4a Locus in Tumor Suppression and Cell Mortality
Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81079-x · Cited by 1,585
Self-citationTumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
Zindy, F., Eischen, C. M., Randle, D. H., Kamijo, T., Cleveland, J. L., Sherr, C. J., & Roussel, M. F. (1998) · Genes & Development · doi:10.1101/gad.12.15.2424 · Cited by 1,245
Alcorta, D. A., Xiong, Y., Phelps, D., Hannon, G., Beach, D., & Barrett, J. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13742 · Cited by 1,008
van der Lugt, N. M., Domen, J., Linders, K., van Roon, M., Robanus-Maandag, E., te Riele, H., van der Valk, M., Deschamps, J., Sofroniew, M., & van Lohuizen, M. (1994) · Genes & Development · doi:10.1101/gad.8.7.757 · Cited by 781
Identification of cooperating oncogenes in Eμ-myc transgenic mice by provirus tagging
van Lohuizen, M., Verbeek, S., Scheljen, B., Wientjens, E., van der Guidon, H., & Berns, A. (1991) · Cell · doi:10.1016/0092-8674(91)90382-9 · Cited by 762
Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer
(1996) · Advances in cancer research · doi:10.1016/s0065-230x(08)60352-8 · Cited by 752
Regulation of p16 CDKN2 Expression and Its Implications for Cell Immortalization and Senescence
Hara, E., Smith, R., Parry, D., Tahara, H., Stone, S., & Peters, G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.859 · Cited by 733
Cited by
Items 701–800 of 1,001
Cardiac Stem and Progenitor Cell Biology for Regenerative Medicine
Torella, D., Ellison, G. M., Nadal‐Ginard, B., & Indolfi, C. (2005) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2005.06.006 · Cited by 54
“and, therefore, inactivates and/or downregulates the two main cell cycle regulators, p53 and pRB (Jacobs et al. 1999), thereby favoring cell growth.”
BackgroundPolycomb Group Genes: Keeping Stem Cell Activity in Balance
Sauvageau, M., & Sauvageau, G. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060113 · Cited by 57
“It was found to regulate proliferation and senescence mainly through repression of the Ink4a locus [18].”
BackgroundBmi-1 regulates self-renewal, proliferation and senescence of human fetal neural stem cells in vitro
Wang, Y., Guan, Y., Wang, F., Huang, A., Wang, S., & Zhang, Y. A. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.04.006 · Cited by 50
Colon cancer stem cells resist antiangiogenesis therapy-induced apoptosis
Lin, S.-P., Lee, Y., Yang, S.-H., Miller, S. A., Chiou, S., Hung, M., & Hung, S. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.08.036 · Cited by 51
Brain Cancer Stem Cells: Current Status on Glioblastoma Multiforme
Facchino, S., Abdouh, M., & Bernier, G. (2011) · Cancers · doi:10.3390/cancers3021777 · Cited by 57
“The Ink4a/Arf locus is also the main target of Bmi1 proliferation-promoting activity in mouse embryonic fibroblasts and cerebellar granule cells [89].”
BackgroundThe c‐MYC–BMI1 axis is essential for SETDB1‐mediated breast tumourigenesis
Xiao, J., Sun, Q., Ding, L., Chien, W., Liu, X., Mayakonda, A., Jiang, Y., Loh, X.-Y., Ran, X., Doan, N., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5126 · Cited by 48
“BMI1 is an oncogene that is involved in maintaining self-renewal of stem cells [9,26], promoting cancer initiation [12,27], and regulating cell cycle G1/S transition [28].”
BackgroundTargeting epigenetic machinery: Emerging novel allosteric inhibitors
Ye, F., Huang, J. L., Wang, H., Luo, C., & Zhao, K. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107406 · Cited by 47
Correlations of BMI-1 expression and telomerase activity in ovarian cancer tissues.
Zhang, F., Sui, L., & Xin, T. (2008) · PubMed · Cited by 47
Polycomb mediates Myc autorepression and its transcriptional control of many loci in Drosophila
Goodliffe, J. M., Wieschaus, E., & Cole, M. D. (2005) · Genes & Development · doi:10.1101/gad.1352305 · Cited by 46
“Control embryos were laid from females of either Gal4 driver corresponding to the one used to drive UAS-dmyc in the experiment.”
BackgroundRichie, E. R., Schumacher, A., Angel, J. M., Holloway, M., Rinchik, E. M., & Magnuson, T. (2002) · Oncogene · doi:10.1038/sj.onc.1205051 · Cited by 51
“Bmi1, but not eed, suppresses expression of the Ink4a locus that encodes the tumor suppressors p16INK4a and p19ARF (Jacobs et al., 1999; Lessard et al., 1999).”
BackgroundmiRNAs in stem cell aging and age-related disease
Choi, S. W., Lee, J. Y., & Kang, K. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.08.013 · Cited by 62
Hajjar, J. E., Chatoo, W., Hanna, R., Nkanza, P., Tétreault, N., Tse, Y. C., Wong, T. P., Abdouh, M., & Bernier, G. (2019) · Scientific Reports · doi:10.1038/s41598-018-37444-3 · Cited by 52
Biology of Polycomb and Trithorax Group Proteins
Breiling, A., Sessa, L., & Orlando, V. (2007) · International review of cytology · doi:10.1016/s0074-7696(07)58002-2 · Cited by 52
Epigenetic Regulation of Hematopoietic Stem Cell Self-Renewal by Polycomb Group Genes
Iwama, A., Oguro, H., Negishi, M., Kato, Y., & Nakauchi, H. (2005) · International Journal of Hematology · doi:10.1532/ijh97.05011 · Cited by 49
de Jonge, H. J. M., de Bont, E. S. J. M., Valk, P. J. M., Schuringa, J. J., Kies, M. P., Woolthuis, C. M., Delwel, R., Veeger, N. J. G. M., Vellenga, E., Löwenberg, B., et al. (2009) · Blood · doi:10.1182/blood-2009-03-212688 · Cited by 49
“Platelets ( 109/L) 56 (3-998) 44* (3-339) 55* (5-998) 66* (8-722)”
Transcription factor E4F1 is essential for epidermal stem cell maintenance and skin homeostasis
Lacroix, M., Caramel, J., Goguet-Rubio, P., Linares, L. K., Estrach, S., Hatchi, E., Rodier, G., Lledo, G., de Bettignies, C., Thepot, A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010167107 · Cited by 55
“Although some evidence suggests that these factors have independent functions, they define a functional cascade with Bmi1 triggering the repression of the Ink4a/Arf locus, whose products, p19 and p16, act as potent inhibitors of p53- and pRb-dependent activities, respectively (29).”
BackgroundMethodLife and death in hematopoietic stem cells
Oguro, H., & Iwama, A. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.05.001 · Cited by 54
Lee, J., Jang, K.-S., Shin, D., Oh, M., Kim, H., Kim, Y.-S., & Kong, G. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2570 · Cited by 49
Belle, J. I., & Nijnik, A. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.03.004 · Cited by 58
Canaani, E., Nakamura, T., Rozovskaia, T., Smith, S. T., Mori, T., Croce, C. M., & Mazo, A. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601639 · Cited by 46
“The demonstration that the mammalian PcG protein BMI-1 regulates the important cell cycle locus INK4a/ARF (Jacobs et al, 1999) suggests that looking for additional ALL-1/TRX targets (e.g. by conditional elimination or activation of the two proteins, followed by DNA microarray analysis) might be rewarding.”
BackgroundFearon, E. R. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.7.515 · Cited by 46
Bmi1 drives hepatocarcinogenesis by repressing the TGFβ2/SMAD signalling axis
Li, B., Chen, Y., Wang, F., Guo, J., Fu, W., Li, M., Zheng, Q., Liu, Y., Fan, L., Li, L., et al. (2019) · Oncogene · doi:10.1038/s41388-019-1043-8 · Cited by 48
Critical role of the Polycomb and Trithorax complexes in the maintenance of CD4 T cell memory
Nakayama, T., & Yamashita, M. (2009) · Seminars in Immunology · doi:10.1016/j.smim.2009.02.001 · Cited by 47
BMI1'S maintenance of the proliferative capacity of laryngeal cancer stem cells
Chen, H., Zhou, L. F., Dou, T., Wan, G., Tang, H.-Q., & Tian, J. (2010) · Head & Neck · doi:10.1002/hed.21576 · Cited by 48
“The oncogenic potential of BMI1 is partly attributed to negative regulation of the INK4A/ARF locus, which encodes p16 and p19 proteins with the function of suppressing proliferation and promoting apoptosis.(8) It has been shown that BMI1 has tumorigenic capacity in lung cancer,(9) breast cancer,(10) colon cancer,(11)…”
BackgroundDetection of novel fusion-transcripts by RNA-Seq in T-cell lymphoblastic lymphoma
López‐Nieva, P., Fernández‐Navarro, P., Graña‐Castro, O., Andrés‐León, E., Santos, J., Villa‐Morales, M., Cobos-Fernández, M., González-Sánchez, L., Malumbres, M., Salazar‐Roa, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-41675-3 · Cited by 45
Shiga, M., Saito, M., Hattori, M., Torii, C., Kosaki, K., Kiyono, T., & Suda, N. (2007) · Cell and Tissue Research · doi:10.1007/s00441-007-0528-x · Cited by 45
“As Bmi-1 can down-regulate the expression of p16Ink4a and p14ARF (Jacobs et al. 1999), it has been used to extend the life span of bovine and human cells (Dimri et al. 2002; Cudre-Mauroux et al. 2003; Itahana et al. 2003; Saito et al. 2005; Haga et al. 2007).”
BackgroundInactivation of Imprinted Genes Induced by Cellular Stress and Tumorigenesis
Pantoja, C., Ríos, L. D. L., Matheu, A., Antequera, F., & Serrano, M. (2005) · Cancer Research · doi:10.1158/0008-5472.26.65.1 · Cited by 53
“Mechanistically, proliferation under in vitro stress results in the progressive derepression of the Ink4a/Arf tumor suppressor locus by epigenetic mechanisms that are in part controlled by Polycomb proteins, such as Bmi1 (4, 6, 7).”
BackgroundHasan, M. K., Yaguchi, T., MINODA, Y., Hirano, T., Taira, K., Wadhwa, R., & Kaul, S. C. (2004) · Biochemical Journal · doi:10.1042/bj20040337 · Cited by 48
Regulation of Stem Cell Differentiation by Histone Methyltransferases and Demethylases
Pasini, D., Bracken, A. P., Agger, K., Christensen, J. F., Hansen, K. H., Cloos, P. A., & Helin, K. (2008) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2008.73.009 · Cited by 47
“…depletion of different PcG members induce premature senescence, whereas overexpression of PcG proteins such as BMI1, EZH2, CBX7, and CBX8 prevents stressed-induced senescence in an INK4A-ARF–dependent manner (Jacobs et al. 1999; Bracken et al. 2003, 2007; Gil et al. 2004; Dietrich et al. 2007).”
BackgroundTransgenic and Knockout Mice Models to Reveal the Functions of Tumor Suppressor Genes
Taneja, P., Zhu, S., Maglic, D., Fry, E. A., Kendig, R. D., & Inoue, K. (2011) · Clinical Medicine Insights Oncology · doi:10.4137/cmo.s7516 · Cited by 50
SOX9 promotes tumor progression through the axis BMI1-p21CIP
Aldaz, P., Otaegi-Ugartemendia, M., Saenz-Antoñanzas, A., García-Puga, M., Moreno-Valladares, M., Flores, J., Gerovska, D., Araúzo-Bravo, M., Samprón, N., Matheu, A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-019-57047-w · Cited by 42
Stem and progenitor cell dysfunction in human trisomies
Liu, B., Filippi, S., Roy, A., & Roberts, I. A. G. (2014) · EMBO Reports · doi:10.15252/embr.201439583 · Cited by 51
“They also went on to demonstrate a link between trisomy for USP16 and reduced activity of the PRC1 complex and its target CDK2NA , which regulate senescence and self-renewal of several somatic stem cell types [106,107; reviewed in 108].”
Pex19p Dampens the p19ARF-p53-p21WAF1 Tumor Suppressor Pathway*
Sugihara, T., Kaul, S. C., Kato, J.-Y., Reddel, R. R., Nomura, H., & Wadhwa, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100011200 · Cited by 44
Polycomb and trithorax opposition in development and disease
Poynter, S. T., & Kadoch, C. (2016) · Wiley Interdisciplinary Reviews Developmental Biology · doi:10.1002/wdev.244 · Cited by 47
“The later observation of senescent phenotypes in BMI1 deficient cells revealed its function as a repressor at the INK4a locus.(130,131) BMI1 was eventually shown to be necessary for H2AK119 monoubiquitination (H2AK119Ub1) activity of the E3 ligase proteins, RING1A and RING1B.”
BackgroundA quantitative model for age-dependent expression of the p16INK4a tumor suppressor
Tsygankov, D., Liu, Y., Sanoff, H. K., Sharpless, N. E., & Elston, T. C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904405106 · Cited by 42
Engelsen, I. B., Mannelqvist, M., Stefansson, I. M., Carter, S. L., Beroukhim, R., Oyan, A. M., Otte, A. P., Kalland, K., Akslen, L. A., & Salvesen, H. B. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604360 · Cited by 43
“…separate them, as BMI-1 has also been found to be important for chromatin remodelling (Shao et al, 1999) and may affect proliferation by repressing the cyclin-dependent kinase inhibitors p16/INK4a and p14/ARF (Jacobs et al, 1999; Jacobs and van Lohuizen, 2002; Pasini et al, 2004; Liu et al, 2006).”
BackgroundAnimal models of melanoma: Recent advances and future prospects
Bardeesy, N. M., Wong, K., DePinho, R. A., & Chin, L. (2000) · Advances in cancer research · doi:10.1016/s0065-230x(00)79004-x · Cited by 47
Self-citationHematopoietic stem cells: generation and manipulation
Nakano, T. (2003) · Trends in Immunology · doi:10.1016/j.it.2003.09.003 · Cited by 43
Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy
Robl, B., Pauli, C., Botter, S. M., Bode‐Lesniewska, B., & Fuchs, B. (2015) · BMC Cancer · doi:10.1186/s12885-015-1397-4 · Cited by 42
“Thus, proliferation can be altered at various levels, for instance through upregulation of BMI1, causing a deactivation of P16 and hence, an increase in proliferation [40].”
BackgroundArnes, J. B., Collett, K., & Akslen, L. A. (2008) · Histopathology · doi:10.1111/j.1365-2559.2007.02957.x · Cited by 42
“Overexpression promotes cell proliferation and immortalizes cells in vitro through suppression of downstream targets p16 and p14.(23) Increased expression of BMI-1 has been found in breast(24) and lung cancer,(25,26) as well as in Hodgkin’s(27) and nonHodgkin’s lymphoma.”
BackgroundZhang, X., Wang, C., Wang, L., Du, L., Wang, S., Zheng, G., Li, W., Zhuang, X., Zhang, X., & Dong, Z. (2011) · International Journal of Cancer · doi:10.1002/ijc.26360 · Cited by 42
Bmi1 Suppresses Adipogenesis in the Hematopoietic Stem Cell Niche
Hu, T., Kitano, A., Luu, V., Dawson, B., Hoegenauer, K. A., Lee, B., & Nakada, D. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.05.027 · Cited by 42
“Since Bmi1 suppresses senescence by silencing the Ink4a/Arf locus (Jacobs et al., 1999), we examined whether Bmi1-deficient BMSCs undergo senescence.”
BackgroundThe Role of Polycomb Group Protein BMI1 in DNA Repair and Genomic Stability
Fitieh, A. M., Locke, A. J., Motamedi, M., & Ismail, I. H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062976 · Cited by 47
Qiu, M., Liang, Z., Chen, L., Tan, G., Wang, K., Liu, L., Liu, J., & Chen, H. (2015) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2015.03.016 · Cited by 44
Korzelius, J., The, I., Ruijtenberg, S., Prinsen, M. B. W., Portegijs, V., Middelkoop, T. C., Koerkamp, M. J. A. G., Holstege, F. C. P., Boxem, M., & van den Heuvel, S. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002362 · Cited by 42
“probably in parallel with chromatin remodeling and modification complexes that induce stable repression of cell cycle genes [3–5].”
BackgroundChew, M. M., Gan, S. Y., Khoo, A. S. B., & Tan, E. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-574 · Cited by 43
“The oncogene, bmi-1, was found to be positively correlated with poor prognosis in NPC patients, thus became a valuable marker for the NPC patients [32-34].”
BackgroundKatsumi, Y., Iehara, T., Miyachi, M., Yagyu, S., Tsubai-Shimizu, S., Kikuchi, K., Tamura, S., Kuwahara, Y., Tsuchiya, K., Kuroda, H., et al. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.08.047 · Cited by 42
AP-1 dimers regulate transcription of the p14/p19ARF tumor suppressor gene
Ameyar‐Zazoua, M., Wisniewska, M. B., Bakiri, L., Wagner, E. F., Yaniv, M., & Weitzman, J. B. (2005) · Oncogene · doi:10.1038/sj.onc.1208424 · Cited by 58
“Other proteins repress transcription of the ARF gene, including Twist, p53, T-box factors and Bmi-1 (Robertson and Jones, 1998; Jacobs et al., 1999; Maestro et al., 1999).”
BackgroundChromosome 9p21 gene copy number and prognostic significance of p16 in ESFT
Brownhill, S. C., Taylor, C., & Burchill, S. A. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603819 · Cited by 42
“The MTAP gene was always co-deleted with CDKN2A, consistent with previous data (Jacobs et al, 1999).”
BackgroundResultCancer, stem cells, and oncolytic viruses
Ribacka, C., Pesonen, S. A., & Hemminki, A. (2008) · Annals of Medicine · doi:10.1080/07853890802021342 · Cited by 50
“Possible mechanisms for deregulation of this pathway in cancer stem cells include p16 methylation and overexpression of the polycomb gene Bmi1, which downregulates p16 (85,86).”
BackgroundUnraveling the complex regulation of stem cells: implications for aging and cancer
Oakley, E. J., & Zant, G. E. V. (2007) · Leukemia · doi:10.1038/sj.leu.2404530 · Cited by 45
Liu, Y., Yang, Y.-M., Xu, H., & Dong, X. (2010) · Diagnostic Molecular Pathology · doi:10.1097/pdm.0b013e3181e202f2 · Cited by 42
A chromatin-independent role of Polycomb-like 1 to stabilize p53 and promote cellular quiescence
Brien, G. L., Healy, E., Jerman, E., Conway, E., Fadda, E., O’Donovan, D., Krivtsov, A. V., Rice, A. M., Kearney, C. J., Flaus, A., et al. (2015) · Genes & Development · doi:10.1101/gad.267930.115 · Cited by 45
Copy number alterations of the polycomb gene BMI1 in gliomas
Häyry, V., Tanner, M., Blom, T., Tynninen, O., Roselli, A., Ollikainen, M., Sariola, H., Wartiovaara, K., & Nupponen, N. N. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0376-0 · Cited by 41
“BMI1 is able to transform, for instance, primary embryo Wbroblasts, murine Wbroblasts, mammary epithelial cells and cerebellar granule cells [7, 8, 12, 21, 22].”
BackgroundPhysical and functional interaction between PML and TBX2 in the establishment of cellular senescence
Martin, N., Benhamed, M., Nacerddine, K., Demarque, M., van Lohuizen, M., Dejean, A., & Bischof, O. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.370 · Cited by 44
“A number of genes have been shown to promote senescence upon loss of function including NF1, PTEN or BMI-1 (Jacobs et al , 1999; Chen et al , 2005; Courtois-Cox et al , 2006); therefore, we decided to focus on genes with decreased expression to study their importance for the senescence program.”
Merve, A., Dubuc, A. M., Zhang, X., Remke, M., Baxter, P. A., Li, X., Taylor, M. D., & Marino, S. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-10 · Cited by 41
“The best characterized function of Bmi1 is the control of proliferation of undifferentiated progenitor cells mainly through repression of the Ink4a/ Arf tumour suppressor gene locus [32,33], which in turn regulates the activity of cyclin D, Cdk4/Cdk6 and p53 (reviewed in [34]).”
BackgroundSelf-citationAP4 directly downregulates p16 and p21 to suppress senescence and mediate transformation
Jackstadt, R., Jung, P., & Hermeking, H. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.282 · Cited by 42
“Further analyses revealed that BMI-1-deficient MEFs show impaired cell cycle progression and undergo premature senescence.(49) Interestingly, BMI-1 and other polycomb-group members occupy the same region of the p16 promoter as AP4, namely the first intron.”
BackgroundPrognostic relevance of Bmi-1 expression and autoantibodies in esophageal squamous cell carcinoma
Liu, W.-L., Guo, X.-Z., Zhang, L.-J., Wang, J.-Y., Zhang, G., Guan, S., Chen, Y.-M., Kong, Q., Xu, L.-H., Li, M.-Z., et al. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-467 · Cited by 41
“regulation by acting as a stable transcriptional repressor of the INK4a/ARF locus[14].”
Polycomb Protein SCML2 Regulates the Cell Cycle by Binding and Modulating CDK/CYCLIN/p21 Complexes
Lecona, E., Rojas, L. A., Bonasio, R., Johnston, A. D., Fernández-Capetillo, Ó., & Reinberg, D. (2013) · PLoS Biology · doi:10.1371/journal.pbio.1001737 · Cited by 45
“In mammals, both PRC1 and PRC2 bind to and repress the INK4a/ Arf locus [52–54], which encodes several proteins involved in cellcycle regulation.”
Backgroundp53 Binds to and Is Required for the Repression of Arf Tumor Suppressor by HDAC and Polycomb
Zeng, Y., Kotake, Y., Pei, X.-H., Smith, M. D., & Xiong, Y. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3483 · Cited by 39
“p53 is required for PRC to bind and repress Arf Previous studies have shown that oncogene Bmi1 promotes cell proliferation and extends the life span of fibroblasts, in part, through repressing both p16 and p19 expression (24, 25).”
Histone Methyltransferase and Histone Methylation in Inflammatory T-Cell Responses
He, S., Tong, Q., Bishop, D. K., & Zhang, Y. (2013) · Immunotherapy · doi:10.2217/imt.13.101 · Cited by 41
Vékony, H., Raaphorst, F. M., Otte, A. P., van Lohuizen, M., Leemans, C. R., van der Waal, I., & Bloemena, E. (2008) · Journal of Clinical Pathology · doi:10.1136/jcp.2007.054262 · Cited by 41
SUZ 12 is a novel putative oncogene promoting tumorigenesis in head and neck squamous cell carcinoma
Wu, Y., Hu, H., Zhang, W., Li, Z., Diao, P., Wang, D., Zhang, W., Wang, Y., Yang, J., & Cheng, J. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13638 · Cited by 41
Qiu, G., Sun, W., Jin, M., Lin, J., Lu, P., & Jin, W. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.12.003 · Cited by 41
Hamid, S., Lim, K. P., Zain, R. B., Ismail, S., Lau, S. H., Mustafa, W. A., Abraham, M., Nam, N. A., Teo, S., & Cheong, S. C. (2007) · International Journal of Molecular Medicine · doi:10.3892/ijmm.19.3.453 · Cited by 43
Di Foggia, V., Zhang, X., Licastro, D., Gerli, M. F. M., Phadke, R., Muntoni, F., Mourikis, P., Tajbakhsh, S., Ellis, M., Greaves, L. C., et al. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20140317 · Cited by 37
“The best characterized molecular mechanisms mediating Bmi1 function relies on transcriptional repression of the ink4a locus, encoding for p16ink4a and p19arf ( Jacobs et al., 1999), as well as of p21waf1/cip1.”
Self-citationDomínguez, E., Iyengar, S., Shannon, H. E., Bleakman, D., Alt, A. J., Arnold, B. M., Bell, M. G., Bleisch, T. J., Buckmaster, J. L., Castano, A. M., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0491952 · Cited by 40
Establishment and Characterization of Immortalized Human Amniotic Epithelial Cells
Zhou, K., Koike, C., Yoshida, T., Okabe, M., Fathy, M., Kyo, S., Kiyono, T., Saito, S., & Nikaido, T. (2013) · Cellular Reprogramming · doi:10.1089/cell.2012.0021 · Cited by 39
“HAE cells were stably introduced with HPV16 E6/E7 and hTERT genes by a retrovirus infection, as described previously ( Jacobs et al., 1999; Takeda et al., 2004).”
BackgroundMethodInfluentialPolycomb (PcG) Proteins, BMI1 and SUZ12, Regulate Arsenic-induced Cell Transformation
Kim, H.-G., Kim, D. J., Li, S., Lee, K. Y., Li, X., Bode, A. M., & Dong, Z. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.360362 · Cited by 43
Pietro, A. D., Polmear, J., Cooper, L., Damelang, T., Hussain, T., Hailes, L., O’Donnell, K., Udupa, V., Tian, M., Preston, S., et al. (2021) · Nature Immunology · doi:10.1038/s41590-021-01077-y · Cited by 42
Ueda, K., Yoshimi, A., Kagoya, Y., Nishikawa, S., Márquez, V. E., Nakagawa, M. M., & Kurokawa, M. (2014) · Cancer Science · doi:10.1111/cas.12386 · Cited by 39
RNA interference against mixed lineage leukemia 5 resulted in cell cycle arrest
Cheng, F., Liu, J., Zhou, S. H., Wang, X. N., Chew, J. F., & Deng, L. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.04.012 · Cited by 43
Zhou, S., Wang, Y., Yang, Y., He, Z., Zhao, R., Zhe, H., Zhang, X., Pan, S., Duan, W., Yang, T., et al. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s73493 · Cited by 45
Tran, M., Jinesh, G. G., McConkey, D. J., & Kamat, A. M. (2010) · Current Stem Cell Research & Therapy · doi:10.2174/157488810793351640 · Cited by 39
“Bmi1, a member of the polycomb family, regulates transcription as a repressor [46, 47].”
BackgroundHistone deacetylases in replicative senescence: evidence for a senescence‐specific form of HDAC‐2
Wagner, M., Brosch, G., Zwerschke, W., Seto, E., Loidl, P., & Jansen‐Dürr, P. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02524-8 · Cited by 46
Retroviral insertion sites and cancer: Fountain of all knowledge?
Neil, J. C., & Cameron, E. R. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00158-7 · Cited by 39
Polycomb Directed Cell Fate Decisions in Development and Cancer
German, B., & Ellis, L. (2022) · Epigenomes · doi:10.3390/epigenomes6030028 · Cited by 37
Clinical Implications of Intestinal Stem Cell Markers in Colorectal Cancer
Espersen, M. L. M., Olsen, J., Linnemann, D., Høgdall, E. V. S., & Troelsen, J. T. (2014) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2014.12.004 · Cited by 45
“BMI1 targets the Ink4a/Arf locus, which encodes the critical cell cycle regulators p16 and p19 (p14 in humans).(81) These are involved in the retinoblastoma protein (Rb) and p53 signaling pathways, regulating cell cycle and apoptosis.”
BackgroundWei, K., Xie, Y., Chen, T., Fu, B., Cui, S., Wang, Y., Cai, G., & Chen, X. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.05.130 · Cited by 38
LncRNAs regulating stemness in aging
Sousa‐Franco, A., Rebelo, K., da Rocha, S. T., & de Jesus, B. B. (2018) · Aging Cell · doi:10.1111/acel.12870 · Cited by 43
Chen, G., Zhang, Y., Yu, S., Sun, W. S., & Miao, D. (2019) · Stem Cells · doi:10.1002/stem.3007 · Cited by 40
Gallardo, A., Molina, A., Asenjo, H. G., López-Onieva, L., Martorell‐Marugán, J., Espinosa-Martínez, M., Griñán‐Lisón, C., Álvarez-Pérez, J. C., Cara, F. E., Navarro-Marchal, S. A., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02375-x · Cited by 40
“Initial studies showed that PcG proteins acted as oncogenes by repressing the tumour suppressor INK4A/ARF (CDKN2A) locus, and therefore inhibiting senescence and favouring cell proliferation [12, 13].”
BackgroundRobson, L. G., Foggia, V. D., Radunović, A., Bird, K., Zhang, X., & Marino, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027116 · Cited by 39
“Polycomb group (PcG) genes are epigenetic chromatin modifiers involved in heritable gene repression and maintenance of stem cell self-renewal and proliferation [13,14].”
BackgroundSelf-citationRetinal degeneration depends on Bmi1 function and reactivation of cell cycle proteins
Zencak, D., Schouwey, K., Chen, D., Ekström, P. A. R., Tanger, E., Bremner, R., van Lohuizen, M., & Arsenijévic, Y. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108297110 · Cited by 40
“Upstream of this pathway, the polycomb group protein Bmi1 promotes CDK4 and CDK6 activity by repressing the Ink4a/Arf locus, encoding the CDK4/6 inhibitor p16 and p19 that activates p53 (17).”
BackgroundMethodInfluentialGong, Y., Yue, J., Wu, X., Wang, X., Wen, J., Lu, L., Peng, X., Qiang, B., & Yuan, J. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl834 · Cited by 40
“We suppose here that NSPc1 is an important transcriptional regulator of p21, whereas Bmi-1 is a key upstream factor of the p16ARF/p19INK4a pathway (9,43).”
BackgroundInfluentialRaaphorst, F. M., Vermeer, M. H., Fieret, E. J. H., Blokzijl, T., Dukers, D. F., Sewalt, R. G. A. B., Otte, A. P., Willemze, R., & Meijer, C. J. L. M. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63143-4 · Cited by 43
“p19, enhanced lymphoproliferation, and eventually malignant transformation of both B and T cells.(35,39,40) Other PcG genes that seem to function as oncogenes are RING1(10) and HPC2,(41) whereas EED(34) and MEL-18(42,43) behave as tumor suppressors.”
BackgroundMaeda, T., Tashiro, H., Katabuchi, H., Begum, M., Ohtake, H., Kiyono, T., & Okamura, H. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602662 · Cited by 38
“…E6 with a mutation of PDZ domain-binding site for the inhibition of p53, E7 for the inhibition of RB, and polycomb family transcriptional repressor Bmi1 for inhibition of p16 (Jacobs et al, 1999), in combination with human telomerase reverse transcriptase (hTERT) for the activation of telomerase.”
BackgroundMethodLiu, Z., Hu, C., Zheng, L., Liu, J., Li, K., Li, X., Wang, Y., Mu, W., Chen, T., Shi, A., et al. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04500-1 · Cited by 38
“For example, BMI1 is first reported to regulate tumor cell proliferation through the Ink4A/Arf locus, encoding tumor suppressors p16 and p19Arf [16, 41].”
BackgroundBmi1 Is Required for Hepatic Progenitor Cell Expansion and Liver Tumor Development
Fan, L., Xu, C., Wang, C., Tao, J., Ho, C., Jiang, L., Gui, B., Huang, S., Evert, M., Calvisi, D. F., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046472 · Cited by 40
“Furthermore, it has been shown that ablation of Ink4a/Arf dramatically reduced the lymphoid and neurological defects in Bmi1 deficient mice [31].”
BackgroundNegishi, M., Saraya, A., Mochizuki, S., Helin, K., Koseki, H., & Iwama, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012373 · Cited by 36
“Bmi1 MEFs undergo premature senescence (,P-6) [15] (Figure S4), and the generation of ROS is reportedly enhanced in the absence of Bmi1 [39].”
BackgroundZhu, D., Wan, X., Huang, H. W., Chen, X., LIANG, W., Zhao, F., Lin, T., Han, J., & Xie, W. (2013) · Oncology Reports · doi:10.3892/or.2013.2919 · Cited by 37
“B-cell-specific Moloney murine leukemia virus insertion site 1 (Bmi1) is a member of the Polycomb group (PcG) gene family, and was initially found to induce lymphoma upon cooperation with c-Myc by inhibiting c-Myc-induced apoptosis via p16INK4a/p14ARF (10,11).”
Leg Amputation Accelerates Senescence of Rat Lumbar Intervertebral Discs
Xing, Q.-J., Liang, Q.-Q., Bian, Q., Ding, D.-F., Cui, X.-Q., Shi, Q., & Wang, Y.-J. (2010) · Spine · doi:10.1097/brs.0b013e3181e7d087 · Cited by 37
A miR-200c/141-BMI1 autoregulatory loop regulates oncogenic activity of BMI1 in cancer cells
Dimri, M., Kang, M., & Dimri, G. P. (2016) · Oncotarget · doi:10.18632/oncotarget.8811 · Cited by 38
“PcG protein BMI1 is an important regulator of proliferation and cell senescence [22, 23].”
BackgroundLee, S. W., Sakakibara, S., Maruo, S., Zhao, B., Calderwood, M. A., Holthaus, A. M., Lai, C.-Y., Takada, K., Kieff, E. D., & Johannsen, E. (2009) · Journal of Virology · doi:10.1128/jvi.01403-09 · Cited by 43
Genetic abnormalities associated with acute lymphoblastic leukemia
Yokota, T., & Kanakura, Y. (2016) · Cancer Science · doi:10.1111/cas.12927 · Cited by 39
Reinisch, C., Kandutsch, S., Uthman, A., & Pammer, J. (2006) · PubMed · doi:10.14670/hh-21.1143 · Cited by 41
Arenzana, T. L., Lianoglou, S., Seki, A., Eidenschenk, C., Cheung, T. K., Seshasayee, D., Hagenbeek, T. J., Sambandam, A., Noubade, R., Peng, I., et al. (2018) · Science Immunology · doi:10.1126/sciimmunol.aal1953 · Cited by 37
Kuijpers, T. W., Ridanpää, M., Peters, M., de Boer, I., Vossen, J. M. J. J., Pals, S. T., Kaitila, I., & Hennekam, R. C. M. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.10.761 · Cited by 37
Role of the alternating reading frame (P19)-p53 pathway in an in vivo murine colon tumor model.
Nambiar, P. R., Giardina, C. A., Guda, K., Aizu, W., Raja, R. G., & Rosenberg, D. W. (2002) · PubMed · Cited by 44
Midgestation lethality in mice deficient for the RecA-related gene,Rad51d/Rad51l3
Pittman, D. L., & Schimenti, J. C. (2000) · genesis · doi:10.1002/(sici)1526-968x(200003)26:3<167::aid-gene1>3.0.co;2-m · Cited by 154
Metadata
- Authors
- Jacobs, J. J. L., Kieboom, K., Marino, S., DePinho, R. A., & van Lohuizen, M.
- Affiliations
- The Netherlands Cancer Institute (NL)
- Harvard University (US)
- Venue
- Nature
- Published
- 1999-01
- Volume
- 397
- Issue
- 6715
- Pages
- 164-168
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1481473039
- Cited by
- 1,580
- References
- 30
- Citations by year
- 2026: 12 · 2025: 15 · 2024: 24 · 2023: 29 · 2022: 36 · 2021: 36 · 2020: 42 · 2019: 43 · 2018: 42 · 2017: 53 · 2016: 71 · 2015: 76 · 2014: 76 · 2013: 76 · 2012: 86
- FWCI
- 16.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- BMI1, Polycomb group proteins, p16, p19ARF, cellular senescence, cell proliferation, cell cycle progression, S phase, transcriptional repression, lymphoma, lymphoid cells, neurological deficit, H-Ras, oncogenic transformation, tumor suppressor
- MeSH terms
- Animals, Cell Cycle, Cell Division, Cells, Cultured, Fibroblasts, Gene Expression Regulation, Humans, Nuclear Proteins, Oncogenes, Proteins, Proto-Oncogene Proteins, Repressor Proteins, Genes, Tumor Suppressor, Cellular Senescence, Mice, Knockout, Cyclin-Dependent Kinase Inhibitor p16, Tumor Suppressor Protein p14ARF, Mice, Polycomb Repressive Complex 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.